About the Company
Established in February 2008, Yatharth Hospital & Trauma Care Services Limited stands among the premier private healthcare institutions in the National Capital Region of Delhi. Boasting three super speciality hospitals in Delhi NCR, namely Noida, Greater Noida, and Noida Extension, Uttar Pradesh, the institution has firmly established its prominence. Notably, the Noida Extension hospital reigns as one of the largest healthcare facilities in the region, furnished with a commendable capacity of 450 beds. Additionally, Yatharth Hospital recently expanded its reach by acquiring a 305-bed hospital in Orchha, Madhya Pradesh, near Jhansi, Uttar Pradesh (“Jhansi-Orchha”), further solidifying its position as a key healthcare provider in the Jhansi-Orchha-Gwalior region.
A workforce of 370 skilled physicians ensures the delivery of comprehensive healthcare services encompassing diverse specialities and super-specialties. The institution’s commitment to exceptional patient care is evident in the establishment of distinct Centers of Excellence (“COE”):
- Center for Medicine
- Center for General Surgery
- Center for Gastroenterology
- Center for Cardiology
- Center for Nephrology and Urology
- Center for Pulmonology
- Center for Neurosciences
- Center for Pediatrics
- Center for Gynecology
- Center for Orthopedics, Spine, and Rheumatology
Equipped with state-of-the-art medical apparatus, including the Azurion cath lab, 1.5 Tesla whole-body MRI with optical digital wideband and embedded express coil technology, advanced non-contrast MR angiography, 128-slice scan CT, endobronchial ultrasound, nerve conduction velocity (“NCV”), capsule endoscopy, thulium uro-laser, flexible scope, advanced laparoscope, advanced microscopes, Qusa, and neuronavigation set, Yatharth Hospital ensures precise diagnosis and surgical procedures. The deployment of such advanced equipment significantly elevates the success rate of surgeries. The modular operating rooms are further enhanced with “HEPA” filters, laminar flow, and surgical microscopes with image intensifiers, solidifying their commitment to patient well-being.
Strengths of Yatharth Hospital IPO:
- A distinguished super-specialty hospital in Delhi NCR, known for its diverse speciality and payer mix.
- Acclaimed for its deployment of advanced, cutting-edge medical technology.
- A magnet for top-tier medical professionals, nurses, paramedical, and support staff.
- Demonstrated stability in operating and financial performance, showing consistent growth.
The objective of Yatharth Hospital IPO: The Company aims to utilize the Net Proceeds of the Fresh Issue to fulfil the following objectives:
- Repayment/prepayment of certain borrowings availed by the Company.
- Repayment/prepayment of certain borrowings availed by the Subsidiaries, namely, AKS Medical & Research Centre Private Limited and Ramraja Multispecialty Hospital & Trauma Centre Private Limited.
- Funding capital expenditure expenses for Noida Hospital and Greater Noida Hospital.
- Funding capital expenditure expenses for the respective hospitals operated by the Subsidiaries, AKS and Ramraja.
- Facilitating inorganic growth initiatives, including acquisitions and other strategic endeavours.
- Catering to general corporate purposes.
In conclusion, Yatharth Hospital & Trauma Care Services Limited takes the lead in pioneering healthcare services, marked by unmatched excellence, cutting-edge technology, and a dedicated team of healthcare professionals.
Yatharth Hospital IPO useful information
Yatharth Hospital IPO Lot Size
|Issue Price||₹285 – 300 Per Share|
|Market Lot:||50 Shares|
|1 Lot Amount:||₹15000|
|Min Small HNI Lots(2-10 Lakh):||700 shares (14 lots)|
|Min Big HNI Lots(10+ Lakh):||3350 shares (67 lots)|
Yatharth Hospital IPO Dates
|IPO Open Date||26-07-2023|
|IPO Close Date||28-07-2023|
|Basis of Allotment|
|Credit of Shares|
to Demat Account*
|IPO Listing Date*||07-08-2023|
Yatharth Hospital IPO Details
|IPO Issue Price:||₹285 – 300 Per Share|
|IPO Listing At:||BSE, NSE|
|Retail Quota:||Not more than 35% of the Net Issue|
|IPO Issue Type:||Book Build Issue|
|IPO Issue Size:||TBD|
|Fresh Issue:||₹490.00 Cr|
|Face Value:||₹10 Per Equity Share|
|Promoter Holding Pre IPO:|||
|Promoter Holding Post IPO:|||
Yatharth Hospital Day-wise IPO GMP Trend
|GMP Date||GMP||Estimated Listing Price||Last Updated Time|
|26-07-2023||₹55||₹355 (18.33%)||26-Jul-2023 11:00 AM|
|27-07-2023||₹53||₹353 (17.67%)||27-Jul-2023 11:30 PM|
|28-07-2023||₹72||₹372 (24.00%)||28-Jul-2023 11:30 PM|
|29-07-2023||₹72||₹372 (24.00%)||29-Jul-2023 10:00 PM|
|30-07-2023||₹85||₹385 (28.33%)||30-Jul-2023 11:30 PM|
|31-07-2023||₹85||₹385 (28.33%)||31-Jul-2023 02:00 PM|
|01-08-2023||₹85||₹385 (28.33%)||1-Aug-2023 07:00 PM|
|02-08-2023||₹75||₹375 (25. 00%)||2-Aug-2023 09:00 PM|
|03-08-2023||₹75||₹375 (25. 00%)||3-Aug-2023 09:00 PM|
|04-08-2023||₹75||₹375 (25. 00%)||4-Aug-2023 04:00 PM|
|05-08-2023||₹75||₹375 (25. 00%)||5-Aug-2023 09:00 PM|
|06-08-2023||₹75||₹375 (25. 00%)||6-Aug-2023 09:00 PM|
Yatharth Hospital IPO Live Subscription (NSE + BSE)
|Day||QIB||NII||SNII (Below ₹10L)||BNII(Above ₹10L)||RII|
|Number of share offered||45,77,004||34,32,754||11,44,251||22,88,503||80,09,759|
|1||26th Jul 2023||0.00x||0.21x||0.35x||0.14x||0.38x|
|2||27th Jul 2023||0.29x||6.08x||7.71x||5.27x||3.53x|
|3||28th Jul 2023||86.37x||38.62x||32.34x||41.76x||8.66x|
Yatharth Hospital Financials for the past 5 Years
|Period Ended||Total Assets||Total Revenue||Profit After Tax||Net Worth||Total Borrowing|
On the IPO GMP Dashboard, you can view the live GMP status of all current and past IPOs (issues that have been closed but have not yet been listed). The performance of the IPO GMP is continually updated by Moneyvigyan.com. The listing price and the IPO GMP can be tracked and compared here on the IPO GMP Dashboard.
Disclaimer: No financial information published anywhere on this site should be interpreted as a recommendation to buy or sell securities or as any other kind of offer to do so. Every piece of material published on this site is just for educational and informational reasons and under no circumstances should be used to make financial decisions. Before actually making any investment decisions based on the information provided here, readers must seek the advice of a licenced financial professional. Any actions made by readers based on the material presented here are done so entirely at their own risk. Investors should be aware that any stock market investment is exposed to unpredictably high market risks. The author has no intention of investing in this IPO.